AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2022

Aug 19, 2022

30071_dirs_2022-08-18_5241c621-e676-409a-af81-6bac4a834dc5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-06-30

Reporting Person: SULPIZIO RICHARD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-18	ResMed Common Stock	A	956	—	Acquired	13823	Direct

Footnotes

F1: Administrative error prevented timely filing.

F2: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2022, or the annual shareholder's meeting in the year following the grant date.